Filing Details

Accession Number:
0001209191-17-058479
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-31 18:15:02
Reporting Period:
2017-10-31
Accepted Time:
2017-10-31 18:15:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610876 Jeffrey Chodakewitz C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp Gmda, Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-31 1,400 $142.38 113,024 No 4 S Direct
Common Stock Disposition 2017-10-31 4,100 $143.46 108,924 No 4 S Direct
Common Stock Disposition 2017-10-31 25,784 $144.46 83,140 No 4 S Direct
Common Stock Disposition 2017-10-31 19,016 $145.26 64,124 No 4 S Direct
Common Stock Disposition 2017-10-31 4,700 $146.52 59,424 No 4 S Direct
Common Stock Disposition 2017-10-31 3,400 $147.75 56,024 No 4 S Direct
Common Stock Disposition 2017-10-31 1,400 $148.40 54,624 No 4 S Direct
Common Stock Disposition 2017-10-31 200 $149.34 54,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $142.38 (range $141.83 to $142.81).
  3. Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $143.46 (range $142.87 to $143.85).
  5. Open market sales reported on this line occurred at a weighted average price of $144.46 (range $143.90 to $144.89).
  6. Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.91 to $145.87).
  7. Open market sales reported on this line occurred at a weighted average price of $146.52 (range $146.16 to $147.14).
  8. Open market sales reported on this line occurred at a weighted average price of $147.75 (range $147.18 to $148.15).
  9. Open market sales reported on this line occurred at a weighted average price of $148.40 (range $148.19 to $148.70).